» Articles » PMID: 34703498

Integrated Computer-aided Formulation Design: A Case Study of Andrographolide/ Cyclodextrin Ternary Formulation

Overview
Date 2021 Oct 27
PMID 34703498
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Current formulation development strongly relies on trial-and-error experiments in the laboratory by pharmaceutical scientists, which is time-consuming, high cost and waste materials. This research aims to integrate various computational tools, including machine learning, molecular dynamic simulation and physiologically based absorption modeling (PBAM), to enhance andrographolide (AG) /cyclodextrins (CDs) formulation design. The lightGBM prediction model we built before was utilized to predict AG/CDs inclusion's binding free energy. AG/γ-CD inclusion complexes showed the strongest binding affinity, which was experimentally validated by the phase solubility study. The molecular dynamic simulation was used to investigate the inclusion mechanism between AG and γ-CD, which was experimentally characterized by DSC, FTIR and NMR techniques. PBAM was applied to simulate the behavior of the formulations, which were validated by cell and animal experiments. Cell experiments revealed that the presence of D-α-Tocopherol polyethylene glycol succinate (TPGS) significantly increased the intracellular uptake of AG in MDCK-MDR1 cells and the absorptive transport of AG in MDCK-MDR1 monolayers. The relative bioavailability of the AG-CD-TPGS ternary system in rats was increased to 2.6-fold and 1.59-fold compared with crude AG and commercial dropping pills, respectively. In conclusion, this is the first time to integrate various computational tools to develop a new AG-CD-TPGS ternary formulation with significant improvement of aqueous solubility, dissolution rate and bioavailability. The integrated computational tool is a novel and robust methodology to facilitate pharmaceutical formulation design.

Citing Articles

Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design.

Vora L, Gholap A, Jetha K, Thakur R, Solanki H, Chavda V Pharmaceutics. 2023; 15(7).

PMID: 37514102 PMC: 10385763. DOI: 10.3390/pharmaceutics15071916.


Emerging Artificial Intelligence (AI) Technologies Used in the Development of Solid Dosage Forms.

Jiang J, Ma X, Ouyang D, Williams 3rd R Pharmaceutics. 2022; 14(11).

PMID: 36365076 PMC: 9694557. DOI: 10.3390/pharmaceutics14112257.


Development of Arteannuin B Sustained-Release Microspheres for Anti-Tumor Therapy by Integrated Experimental and Molecular Modeling Approaches.

Wang Y, Huang W, Wang N, Ouyang D, Xiao L, Zhang S Pharmaceutics. 2021; 13(8).

PMID: 34452197 PMC: 8399913. DOI: 10.3390/pharmaceutics13081236.

References
1.
Jambhekar S, Breen P . Cyclodextrins in pharmaceutical formulations II: solubilization, binding constant, and complexation efficiency. Drug Discov Today. 2015; 21(2):363-8. DOI: 10.1016/j.drudis.2015.11.016. View

2.
Sun L, Zhang B, Sun J . The Solubility-Permeability Trade-Off of Progesterone With Cyclodextrins Under Physiological Conditions: Experimental Observations and Computer Simulations. J Pharm Sci. 2017; 107(1):488-494. DOI: 10.1016/j.xphs.2017.09.032. View

3.
Houk K, Leach A, Kim S, Zhang X . Binding affinities of host-guest, protein-ligand, and protein-transition-state complexes. Angew Chem Int Ed Engl. 2003; 42(40):4872-97. DOI: 10.1002/anie.200200565. View

4.
Li M, Zou P, Tyner K, Lee S . Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles. AAPS J. 2016; 19(1):26-42. DOI: 10.1208/s12248-016-0010-3. View

5.
Yu H, Hu Y, Ip F, Zuo Z, Han Y, Ip N . Intestinal transport of bis(12)-hupyridone in Caco-2 cells and its improved permeability by the surfactant Brij-35. Biopharm Drug Dispos. 2011; 32(3):140-50. DOI: 10.1002/bdd.745. View